Nanomedicine News

RSS

FDA Clears Ignyta's IND for RXDX-107 Alkyl Ester of Bendamustine Encapsulated in HSA to Form Nanoparticles

Ignyta, Inc., a precision oncology biotechnology company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug application (IND) for Ignyta’s new chemical entity RXDX-107, a next-generation alkyl ester of bendamustine encapsulated in human serum albumin (HSA) to form nanoparticles.

30 Jul 2015

Researchers Aim to Grow Nanoflowers Seeded from Metal Nanoparticles Producing Fractals that Mimic Neurons

Richard Taylor's vision of using artificial fractal-based implants to restore sight to the blind -- part of a far-reaching concept that won an innovation award this year from the White House -- is now covered under a broad U.S. patent.

29 Jul 2015

MonoSol Rx Initiates Phase 2a Study for Midaform® Insulin PharmFilm®, MSL- 001

MonoSol Rx, the developer of PharmFilm drug delivery technology, with its partner Midatech Pharma, announced today that it has initiated a Phase 2a study for Midaform® Insulin PharmFilm®, MSL- 001, with the dosing of its first patient.

28 Jul 2015

Matinas BioPharma Announces Presentation of Preclinical Data on Encochleated Atovaquone at IDWeek 2015

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective antifungal and anti-bacterial therapeutics for the treatment of serious and life-threatening infections, today announced that preclinical data on encochleated atovaquone (CATQ) will be presented at IDWeek 2015 Oct. 7-11 in San Diego.

28 Jul 2015

New License Enables Use of Innova’s Lightning-Link and InnovaCoat GOLD Technologies in Mologic’s Kits

Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, and Mologic, a specialist diagnostic development company and molecular reagent innovator, announced today the signing of a supply and licensing agreement for use of Innova’s Lightning-Link® and InnovaCoat® GOLD technologies as part of Mologic’s commercial assay development services and range of immunoassays.

28 Jul 2015

ACPHS to Host Symposium and Workshop on Latest Advances in Nanomedicine

The Pharmaceutical Research Institute at Albany College of Pharmacy and Health Sciences (ACPHS) will host a Symposium and Workshop August 3-7 to explore the latest advances in the field of Nanomedicine. The event will take place in the Gozzo Student Center located on the ACPHS Campus.

24 Jul 2015

Researchers Create Artificial Version of Transcription Factor Using Gold Nanoparticles

Stem cells hold great potential for addressing a variety of conditions from spinal cord injuries to cancer, but they can be difficult to control. Scientists are now reporting in the journal ACS Nano a new way to mimic the body's natural approach to programming these cells.

23 Jul 2015

ONXEO Provides Update on Nanoparticle-Based Livatag Phase III Trial for Hepatocellular Carcinoma

Onxeo S.A., an innovative company specializing in the development of orphan oncology drugs, updates on the clinical development status of ReLive , the Livatag®phase III trial in the treatment of hepatocellular carcinoma.

22 Jul 2015

WHO Teleconference: Novavax Reports Top-Line Data from Ebola GP Recombinant Nanoparticle Vaccine Clinical Trial

Novavax, Inc., a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced positive top-line data from a Phase 1 clinical trial of its Ebola virus glycoprotein (GP) recombinant nanoparticle vaccine candidate adjuvanted with Matrix-M™ as part of the World Health Organization’s (WHO) Fifth Teleconference on Ebola Vaccine Clinical Trials.

From Novavax Inc. 22 Jul 2015

Cerulean Commences Dosing in CRLX101-Weekly Paclitaxel Phase 1b Clinical Trial for Relapsed Ovarian Cancer

Cerulean Pharma Inc. today announced that the first patient has been dosed in an open label Phase 1b clinical trial of its lead product candidate, CRLX101, in combination with weekly paclitaxel in patients with relapsed ovarian cancer by the University of Virginia School of Medicine. This trial is being conducted by Cerulean in collaboration with the GOG Foundation under the direction of principal investigator, Carolyn N. Krasner, M.D., of the Massachusetts General Hospital Cancer Center.

22 Jul 2015

Nanomedicine News

FDA Clears Ignyta's IND for RXDX-107 Alkyl Ester of Bendamustine Encapsulated in HSA to Form Nanoparticles

Researchers Aim to Grow Nanoflowers Seeded from Metal Nanoparticles Producing Fractals that Mimic Neurons

MonoSol Rx Initiates Phase 2a Study for Midaform® Insulin PharmFilm®, MSL- 001

Matinas BioPharma Announces Presentation of Preclinical Data on Encochleated Atovaquone at IDWeek 2015

New License Enables Use of Innova’s Lightning-Link and InnovaCoat GOLD Technologies in Mologic’s Kits

ACPHS to Host Symposium and Workshop on Latest Advances in Nanomedicine

Researchers Create Artificial Version of Transcription Factor Using Gold Nanoparticles

ONXEO Provides Update on Nanoparticle-Based Livatag Phase III Trial for Hepatocellular Carcinoma

WHO Teleconference: Novavax Reports Top-Line Data from Ebola GP Recombinant Nanoparticle Vaccine Clinical Trial

Cerulean Commences Dosing in CRLX101-Weekly Paclitaxel Phase 1b Clinical Trial for Relapsed Ovarian Cancer

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Sustainable ZnO Nanoparticles for Methylene Blue Cleanup

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials